Alzheimer’s risks may increase with prostate cancer treatment
In dealing with cancer, a New York health care practitioner may find that some treatments involve certain risk factors. This means that it is important to work with a patient to find the right balance between treatment and risk. In the case of treating prostate cancer, for example, a primary approach to addressing the disease involves androgen deprivation therapy due to the role that testosterone can have in causing tumors to grow. A study, however, indicates that there may be a greater potential for a patient going through ADT to later be diagnosed with Alzheimer’s.